Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

MK-386 reduces sebum DHT levels.

Marine sponges from Tabuhan Island can inhibit enzymes linked to Alzheimer's and hair loss.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Finasteride's molecular properties and active sites were identified using computational methods.

Finasteride may help improve certain brain function issues linked to dopamine.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

5-ARI therapy may help prevent prostate cancer progression.

Store Tectona grandis leaf extracts in slightly acidic, light-protected conditions for best stability.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Shorter GGC triplet repeats in the androgen receptor gene are linked to less hair loss in Han men.

Finasteride's metabolites were identified, helping understand how the drug is processed in the body.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

New compounds show promise as nonsteroidal treatments for hair loss.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.